-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,772.55(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 114.0
- ISIN : INE059A01026
-
Today’s Low
1,513.50 -
Today’s High
1,566.70

-
Open
1,556.00 -
Perv Close
1,551.70 -
52W Low
1,317.25 -
52W High
1,702.05
Key Indicators
-
P/E(TTM)
26.47
-
Mar.Cap (₹Cr.)
123,234.30
-
Div & Yield %
0.85
-
Book Value(₹)
360.74
-
Debt-Equity Ratio
-1.66
-
AGM Date
25-Apr-2025
-
EPS
57.63
-
P/E Ratio
26.47
Financials Ratios
-
Debt-Equity Ratio
0.03
-
Mar.Cap (₹Cr.)
123,234.30
-
RONW (%)
16.58
-
ROCE (%)
22.27
Score Board
-
Equity (₹ in Cr.)
161.52
-
BV (₹)
360.70
-
Sales( ₹ in Cr.)
16,574.34
-
NP (in Cr.)
4,034.33
-
NP Var(%)
58.0
-
Div%
650.0
-
CPS (₹)
57.20
-
EPS (₹)
50.00
-
Traded Value (₹ in Lakhs)
125,285.64
-
52 Week High
1,702.05
-
52 Week Low
1,317.25
-
Price BSE
1551.0
-
Price NSE
1,552.00
-
Market Capital( in Cr.)
125,285.64
-
P/C Ratio
27.10
-
P/E Ratio
31.00
-
Price Vs.BV
50.00
-
21-Apr-2025( 11:32)
Hot Pursuit - Cipla... - According to an exchange filin...
-
17-Apr-2025( 04:12)
Corporate News - Cipla... - Cipla has allotted 23,282 full...
-
11-Apr-2025( 10:12)
Hot Pursuit - Cipla... - <p> Cipla's formulation is an...
-
11-Apr-2025( 09:27)
Corporate News - Cipla... - Cipla has received final appro...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 | 12,374.01 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 | 12,374.01 |
Other Income | 1,433.72 | 826.20 | 742.05 | 653.91 | 892.85 | 577.52 |
Stock Adjustments | -104.57 | -194.32 | 541.93 | -6.41 | 43.08 | -136.70 |
Total Income | 17,903.49 | 14,977.22 | 16,664.80 | 11,950.21 | 13,595.08 | 12,814.83 |
EXPENDITURE : | ||||||
Raw Materials | 4,977.62 | 4,739.89 | 6,467.54 | 4,097.20 | 4,362.29 | 4,371.46 |
Power and Fuel Cost | 271.66 | 257.07 | 247.58 | 234.58 | 253.95 | 264.93 |
Employee Cost | 2,644.21 | 2,335.69 | 2,122.02 | 1,703.58 | 1,911.08 | 1,839.84 |
Other Manufacturing Expenses | 1,243.47 | 988.99 | 994.55 | 906.09 | 921.04 | 861.96 |
Selling and Administration Expenses | 2,510.53 | 2,334.97 | 2,107.17 | 1,578.59 | 2,093.92 | 2,030.01 |
Miscellaneous Expenses | 338.13 | 327.42 | 272.66 | -291.15 | 452.66 | 367.11 |
Employee Benefit Expenses | 2,644.21 | 2,335.69 | 2,122.02 | 1,703.58 | 1,911.08 | 1,839.84 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 11,985.62 | 10,984.03 | 12,211.52 | 8,228.89 | 9,994.94 | 9,735.31 |
Operating Profit | 5,917.87 | 3,993.19 | 4,453.28 | 3,721.32 | 3,600.14 | 3,079.52 |
Interest | 20.25 | 22.27 | 26.93 | 45.07 | 36.05 | 16.97 |
Gross Profit | 5,897.62 | 3,970.92 | 4,426.35 | 3,676.25 | 3,564.09 | 3,062.55 |
Depreciation | 587.59 | 595.91 | 546.62 | 468.62 | 599.78 | 569.72 |
Profit Before Tax | 5,310.03 | 3,375.01 | 3,879.73 | 3,207.63 | 2,964.31 | 2,492.83 |
Current Tax | 1,226.69 | 901.63 | 949.49 | 756.27 | 545.96 | 576.43 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 6.09 | -40.09 | -27.69 | -16.92 | 100.18 | 27.99 |
Reported Net Profit | 4,077.25 | 2,513.47 | 2,957.93 | 2,468.28 | 2,318.17 | 1,888.41 |
Extraordinary Items | 42.92 | -41.59 | 48.88 | 39.09 | 91.40 | 79.15 |
Adjusted Net Profit | 4,034.33 | 2,555.06 | 2,909.05 | 2,429.19 | 2,226.77 | 1,809.26 |
Adjustment below Net Profit | -74.47 | -10.52 | 18.48 | 13.71 | -49.53 | -32.59 |
P & L Balance brought forward | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 | 10,828.56 | 9,214.31 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 686.17 | 403.50 | 403.35 | 0.00 | 617.48 | 241.57 |
P & L Balance carried down | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 | 10,828.56 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 322.49 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 650.00 | 425.00 | 250.00 | 250.00 | 200.00 | 150.00 |
Dividend Per Share(Rs) | 13.00 | 8.50 | 5.00 | 5.00 | 4.00 | 3.00 |
Earnings Per Share-Unit Curr | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 | 23.44 |
Earnings Per Share(Adj)-Unit Curr | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 | 23.44 |
Book Value | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 | 195.88 |
Book Value(Adj)-Unit Curr | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 | 195.88 |